Skip to main content
. Author manuscript; available in PMC: 2016 May 17.
Published in final edited form as: J Allergy Clin Immunol Pract. 2015 Nov 7;4(1):38–59. doi: 10.1016/j.jaip.2015.07.025

TABLE II.

Differences between the definition of CVID ICON vs Ameratunga et al16

CVID ICON Ameratunga et al16
The diagnosis is “definite” if all criteria are met. The diagnosis is “probable” if all criteria are met.
“Probable” or “possible” CVID is not defined. Both “probable” and “possible” CVID are defined; there is no “definite” CVID.
Serum IgG level must be below local/regional clinical
  laboratory norms.
Serum IgG must be <5 g/L for all.
IgA or IgM must be low (IgA low preferred). IgA or IgM may be low, but neither is required to be low.
Impaired vaccine response is required for the diagnosis. Impaired vaccine response may be supportive of the diagnosis, but is not required.
The diagnosis may be established solely on the basis of
  laboratory criteria.
Some symptom/clinical manifestation must be present for “probable” CVID.
The diagnosis is not influenced by additional laboratory
  criteria.
“Probable” CVID may be established with supportive laboratory criteria (low IgG3, low
  memory B cells, increased CD21, low B cells, autoantibodies) and genetic alterations
  (TACI, BAFFR, MSH5, and others).
The diagnosis does not depend on histological criteria. “Probable” CVID may be established with supportive histological criteria (granulomas,
  lung or gastrointestinal disease).

ICON, International Consensus.